[20181227]IF11058_药品短缺:原因、FDA授权和政策选择.pdf

上传人:任我行 文档编号:27776 上传时间:2022-06-24 发布时间:2019-03-21 格式:PDF 页数:3 大小:422.66KB
下载 相关 举报
[20181227]IF11058_药品短缺:原因、FDA授权和政策选择.pdf_第1页
第1页 / 共3页
[20181227]IF11058_药品短缺:原因、FDA授权和政策选择.pdf_第2页
第2页 / 共3页
[20181227]IF11058_药品短缺:原因、FDA授权和政策选择.pdf_第3页
第3页 / 共3页
亲,该文档总共3页,全部预览完了,如果喜欢就下载吧!
资源描述

1、 https:/crsreports.congress.gov December 27, 2018Drug Shortages: Causes, FDA Authority, and Policy OptionsDrug shortages have remained a serious and persistent public health concern, despite the prevention and mitigation efforts of Congress, the Food and Drug Administration (FDA), and health care pr

2、oviders. While the number of new drug shortages has declined since its peak in 2011, many medically necessary products, such as sterile saline solution and sodium bicarbonate, remain in shortage. According to FDA, some active drug shortages have persisted for more than eight years. Figure 1. Number

3、of New Drug Shortages, 2010-2017 Source: FDA annual reports on drug shortages for calendar years 2015, 2016, and 2017. Presentation from November 27, 2018, public meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions,” https:/healthpolicy.duke.edu/sites/default/files

4、/atoms/files/duke-fda_drug_shortages_presentation_slides_0.pdf. Causes of drug shortages include manufacturing and quality issues (e.g., contaminants); lack of transparency (e.g., lack of information about drug quality and supply reliability); and business decisions made by individual firms (e.g., l

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告